ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE

ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE was reported 17048 times

ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTRACRANIAL VENOUS SINUS STENOSIS 7 0.3889
1 MEDICATION OVERUSE HEADACHE 193 0.2255
2 POSTNATAL GROWTH RESTRICTION 10 0.0763
3 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 15 0.0633
4 DRUG EFFECT VARIABLE 64 0.0565
5 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1570 0.0535
6 OPTIC DISC HAEMORRHAGE 8 0.0349
7 EMERGENCY CARE EXAMINATION 21 0.0310
8 DRUG EFFECT FASTER THAN EXPECTED 9 0.0270
9 THUNDERCLAP HEADACHE 6 0.0229
10 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 10 0.0200
11 THERAPEUTIC PRODUCT EFFECT VARIABLE 70 0.0180
12 NO ADVERSE DRUG EFFECT 12 0.0177
13 FOREIGN BODY TRAUMA 11 0.0150
14 DRUG WITHDRAWAL HEADACHE 6 0.0145
15 GALLBLADDER CHOLESTEROLOSIS 6 0.0132
16 PRODUCT USED FOR UNKNOWN INDICATION 16 0.0127
17 OPIATES POSITIVE 6 0.0125
18 TRANSVERSE SINUS THROMBOSIS 6 0.0114
19 ULCER HAEMORRHAGE 75 0.0111
20 STOMACH DISCOMFORT 49 0.0095
21 AMPHETAMINES POSITIVE 7 0.0093
22 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 18 0.0091
23 CHOLECYSTITIS CHRONIC 61 0.0091
24 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
25 CERVIX DISORDER 6 0.0083
26 PRODUCT USE IN UNAPPROVED INDICATION 2056 0.0083
27 BILIARY DYSKINESIA 14 0.0082
28 CLUSTER HEADACHE 11 0.0080
29 PRE-EXISTING CONDITION IMPROVED 49 0.0078
30 FEELING JITTERY 146 0.0077
31 PRETERM PREMATURE RUPTURE OF MEMBRANES 9 0.0075
32 THERAPEUTIC RESPONSE UNEXPECTED 333 0.0074
33 DRUG EFFECT LESS THAN EXPECTED 105 0.0071
34 GALLBLADDER INJURY 13 0.0067
35 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 45 0.0066
36 MIGRAINE 598 0.0063
37 ULCER 95 0.0060
38 GASTRIC PERFORATION 16 0.0059
39 ALLERGY TO ANIMAL 6 0.0056
40 GASTRIC ULCER 107 0.0056
41 EPIGASTRIC DISCOMFORT 21 0.0054
42 DRUG ABUSER 33 0.0054
43 REBOUND ACID HYPERSECRETION 15 0.0050
44 CATAPLEXY 7 0.0049
45 GASTRIC ULCER HAEMORRHAGE 27 0.0049
46 ACCIDENTAL EXPOSURE 20 0.0048
47 MIGRAINE WITH AURA 13 0.0048
48 INCORRECT DOSAGE ADMINISTERED 23 0.0047
49 OBSTRUCTION GASTRIC 6 0.0047
50 GESTATIONAL HYPERTENSION 6 0.0046
51 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 255 0.0046
52 PRODUCT PACKAGE ASSOCIATED INJURY 10 0.0045
53 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 32 0.0045
54 IDIOPATHIC INTRACRANIAL HYPERTENSION 10 0.0044
55 THERAPEUTIC PRODUCT EFFECT DELAYED 20 0.0044
56 ESSENTIAL HYPERTENSION 8 0.0044
57 GASTRIC HAEMORRHAGE 49 0.0043
58 SLEEP PARALYSIS 6 0.0041
59 EXPIRED DRUG ADMINISTERED 20 0.0040
60 PRODUCT TAMPERING 7 0.0039
61 GASTRIC DISORDER 133 0.0039
62 GASTRITIS EROSIVE 18 0.0039
63 PRODUCT ADMINISTRATION INTERRUPTED 30 0.0038
64 AURA 7 0.0037
65 DRUG EFFECT DELAYED 17 0.0037
66 FOREIGN BODY 15 0.0037
67 TUNNEL VISION 7 0.0037
68 SNORING 14 0.0037
69 INTENTIONAL MISUSE 7 0.0037
70 INTESTINAL POLYP 6 0.0036
71 DRUG SCREEN FALSE POSITIVE 10 0.0036
72 GASTROINTESTINAL ULCER 8 0.0036
73 DRUG SCREEN POSITIVE 28 0.0035
74 BLOOD CHLORIDE INCREASED 6 0.0035
75 SPONDYLOLISTHESIS 6 0.0035
76 FACE INJURY 13 0.0034
77 INFUSION SITE DISCHARGE 6 0.0034
78 PREMATURE LABOUR 19 0.0034
79 PEPTIC ULCER 11 0.0033
80 CEREBRAL VENOUS THROMBOSIS 6 0.0033
81 ACCIDENTAL DRUG INTAKE BY CHILD 5 0.0033
82 NEPHROGENIC ANAEMIA 15 0.0032
83 HYPERPARATHYROIDISM SECONDARY 8 0.0032
84 EXPIRED PRODUCT ADMINISTERED 105 0.0032
85 HYPERCOAGULATION 6 0.0031
86 BILIARY COLIC 9 0.0031
87 CONTRAINDICATED PRODUCT ADMINISTERED 93 0.0031
88 SINUS HEADACHE 18 0.0030
89 DRUG ADMINISTRATION ERROR 92 0.0030
90 TEMPOROMANDIBULAR JOINT SYNDROME 8 0.0030
91 INCORRECT DRUG ADMINISTRATION DURATION 84 0.0030
92 HYPERACUSIS 11 0.0030
93 MEDICATION ERROR 162 0.0029
94 PARANASAL SINUS DISCOMFORT 11 0.0029
95 DRUG INEFFECTIVE 3817 0.0029
96 HANGOVER 10 0.0028
97 PRODUCT COMPLAINT 71 0.0028
98 DUODENAL ULCER HAEMORRHAGE 8 0.0028
99 TENSION HEADACHE 12 0.0028
100 HYPERTONIC BLADDER 8 0.0028
101 GESTATIONAL DIABETES 13 0.0027
102 CHOLELITHIASIS 89 0.0027
103 FEELING DRUNK 20 0.0027
104 POST-TRAUMATIC STRESS DISORDER 18 0.0027
105 SLEEP APNOEA SYNDROME 50 0.0026
106 DRUG EFFECT INCOMPLETE 95 0.0026
107 POOR QUALITY SLEEP 56 0.0026
108 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 185 0.0026
109 TACHYPHRENIA 9 0.0026
110 SOMNAMBULISM 17 0.0026
111 BLADDER PAIN 8 0.0025
112 INTENTIONAL DRUG MISUSE 52 0.0025
113 SPONDYLITIS 9 0.0025
114 SEASONAL ALLERGY 35 0.0025
115 ABDOMINAL PAIN UPPER 505 0.0025
116 INITIAL INSOMNIA 25 0.0024
117 PAPILLOEDEMA 11 0.0024
118 DEVICE INFUSION ISSUE 6 0.0024
119 MATERNAL EXPOSURE TIMING UNSPECIFIED 9 0.0024
120 EXTRA DOSE ADMINISTERED 96 0.0024
121 OESOPHAGEAL DISORDER 9 0.0023
122 PRODUCT QUALITY ISSUE 317 0.0023
123 SUSPECTED COUNTERFEIT PRODUCT 9 0.0023
124 VITAMIN D DEFICIENCY 22 0.0023
125 YAWNING 6 0.0022
126 DYSPEPSIA 221 0.0022
127 EUPHORIC MOOD 23 0.0022
128 GALLBLADDER DISORDER 40 0.0022
129 ABDOMINAL DISCOMFORT 375 0.0022
130 REBOUND EFFECT 25 0.0022
131 DRUG TOLERANCE 11 0.0022
132 SPINAL OSTEOARTHRITIS 19 0.0022
133 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19 0.0021
134 THERAPEUTIC RESPONSE DELAYED 6 0.0021
135 CEREBRAL THROMBOSIS 6 0.0021
136 INTERVERTEBRAL DISC DISORDER 9 0.0021
137 MICTURITION URGENCY 24 0.0021
138 SCOLIOSIS 13 0.0021
139 HIATUS HERNIA 27 0.0021
140 OESOPHAGEAL ULCER 8 0.0021
141 UNDERDOSE 151 0.0021
142 CONCUSSION 16 0.0021
143 HEPATIC CYST 7 0.0021
144 FIBROMYALGIA 50 0.0021
145 DECREASED INTEREST 12 0.0020
146 LACERATION 19 0.0020
147 NERVOUSNESS 105 0.0020
148 PAROSMIA 15 0.0020
149 SENSORY LOSS 16 0.0020
150 ENURESIS 8 0.0020
151 MUSCLE TIGHTNESS 32 0.0020
152 SINUS DISORDER 39 0.0020
153 PHOTOPHOBIA 37 0.0020
154 DUODENITIS 6 0.0020
155 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
156 FEELING OF DESPAIR 9 0.0019
157 OVERDOSE 414 0.0019
158 WRIST FRACTURE 23 0.0019
159 INFUSION SITE PRURITUS 6 0.0019
160 OVARIAN CYST 19 0.0019
161 THERAPEUTIC RESPONSE CHANGED 12 0.0019
162 URINE ODOUR ABNORMAL 11 0.0019
163 CHRONIC SINUSITIS 7 0.0019
164 INFUSION SITE PAIN 24 0.0019
165 DRUG DEPENDENCE 298 0.0019
166 AUTOIMMUNE THYROIDITIS 7 0.0018
167 IMPAIRED DRIVING ABILITY 21 0.0018
168 HEADACHE 1154 0.0018
169 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
170 COELIAC DISEASE 18 0.0018
171 INCORRECT DOSE ADMINISTERED 414 0.0018
172 END STAGE RENAL DISEASE 33 0.0018
173 TINNITUS 83 0.0018
174 LIVE BIRTH 15 0.0018
175 INTERVERTEBRAL DISC PROTRUSION 39 0.0018
176 RETCHING 38 0.0018
177 MENINGITIS ASEPTIC 8 0.0018
178 ANAL INCONTINENCE 16 0.0018
179 INTRACRANIAL ANEURYSM 7 0.0017
180 PHOTOPSIA 11 0.0017
181 MUSCLE STRAIN 15 0.0017
182 HUNGER 24 0.0017
183 DENTAL CARIES 19 0.0017
184 HYPERURICAEMIA 7 0.0017
185 CARDIAC FLUTTER 11 0.0017
186 CHRONIC KIDNEY DISEASE 129 0.0017
187 BOWEL MOVEMENT IRREGULARITY 13 0.0017
188 CHOLECYSTITIS 20 0.0017
189 PANIC ATTACK 61 0.0017
190 ROAD TRAFFIC ACCIDENT 70 0.0017
191 INSOMNIA 444 0.0017
192 INFUSION SITE ERYTHEMA 14 0.0017
193 MULTIPLE ALLERGIES 13 0.0017
194 BIPOLAR DISORDER 18 0.0017
195 FOOD INTOLERANCE 6 0.0016
196 VITAMIN D DECREASED 14 0.0016
197 GASTROINTESTINAL PAIN 18 0.0016
198 TOOTH FRACTURE 18 0.0016
199 ALCOHOL USE 6 0.0016
200 APPLICATION SITE BURN 8 0.0016
201 NERVE INJURY 18 0.0016
202 ACTIVITIES OF DAILY LIVING IMPAIRED 32 0.0016
203 FEELING ABNORMAL 387 0.0016
204 TOOTH INJURY 7 0.0016
205 ABDOMINAL TENDERNESS 8 0.0016
206 PALPITATIONS 188 0.0016
207 PARAESTHESIA ORAL 23 0.0016
208 FORMICATION 11 0.0016
209 HAEMATEMESIS 40 0.0016
210 BACK INJURY 17 0.0016
211 ATELECTASIS 15 0.0016
212 SKIN WARM 9 0.0015
213 GASTROOESOPHAGEAL REFLUX DISEASE 124 0.0015
214 SYNOVIAL CYST 7 0.0015
215 BLADDER DISORDER 15 0.0015
216 PHARYNGOLARYNGEAL PAIN 8 0.0015
217 HYSTERECTOMY 13 0.0015
218 PHARYNGEAL OEDEMA 23 0.0015
219 PRODUCT PHYSICAL ISSUE 30 0.0015
220 PRODUCT USE ISSUE 279 0.0015
221 COLITIS ISCHAEMIC 10 0.0015
222 SPINAL COLUMN STENOSIS 7 0.0015
223 TENSION 9 0.0015
224 FAECES DISCOLOURED 32 0.0015
225 LIMB INJURY 40 0.0015
226 SELF-MEDICATION 6 0.0015
227 ECCHYMOSIS 10 0.0015
228 FAECAL INCONTINENCE 7 0.0015
229 FACIAL PAIN 13 0.0015
230 EYE SWELLING 54 0.0015
231 CHOKING SENSATION 8 0.0014
232 CYST 18 0.0014
233 GASTRITIS 38 0.0014
234 TOOTHACHE 26 0.0014
235 DISSOCIATION 11 0.0014
236 HEART RATE INCREASED 142 0.0014
237 DYSMENORRHOEA 19 0.0014
238 INFUSION SITE SWELLING 9 0.0014
239 BLEPHAROSPASM 9 0.0014
240 RENAL PAIN 15 0.0014
241 BRAIN NEOPLASM 13 0.0014
242 CHOLECYSTITIS ACUTE 8 0.0014
243 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
244 ANEURYSM 7 0.0014
245 IRRITABLE BOWEL SYNDROME 30 0.0014
246 PRODUCT USE COMPLAINT 22 0.0014
247 NECK PAIN 78 0.0014
248 BLOOD MAGNESIUM DECREASED 12 0.0014
249 HORDEOLUM 6 0.0014
250 PANIC REACTION 10 0.0014
251 HYPERVENTILATION 8 0.0014
252 NEPHROLITHIASIS 63 0.0014
253 WALKING AID USER 9 0.0014
254 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 97 0.0014
255 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
256 WHEELCHAIR USER 6 0.0013
257 HYPOAESTHESIA 202 0.0013
258 PREGNANCY 27 0.0013
259 RHINITIS ALLERGIC 6 0.0013
260 TENDERNESS 14 0.0013
261 PAIN IN JAW 38 0.0013
262 INTENTIONAL PRODUCT MISUSE 117 0.0013
263 NAUSEA 1055 0.0013
264 CHOKING 26 0.0013
265 GASTROENTERITIS VIRAL 24 0.0013
266 HEPATOMEGALY 13 0.0013
267 RESTLESS LEGS SYNDROME 24 0.0013
268 SCIATICA 21 0.0013
269 DERMATITIS CONTACT 15 0.0013
270 EXOSTOSIS 12 0.0013
271 CHOLECYSTECTOMY 15 0.0013
272 JOINT INJURY 28 0.0013
273 SWELLING FACE 85 0.0013
274 HEREDITARY ANGIOEDEMA 14 0.0013
275 INCREASED TENDENCY TO BRUISE 12 0.0013
276 IRON DEFICIENCY ANAEMIA 12 0.0013
277 BRUXISM 7 0.0013
278 STRESS FRACTURE 7 0.0013
279 LOCALISED OEDEMA 6 0.0013
280 PHARYNGITIS STREPTOCOCCAL 14 0.0013
281 HIP SURGERY 7 0.0013
282 BACK DISORDER 21 0.0013
283 ANXIETY 366 0.0013
284 SCAR 22 0.0013
285 HYDROCEPHALUS 7 0.0013
286 CHROMATURIA 29 0.0013
287 UMBILICAL HERNIA 6 0.0013
288 DRUG EFFECT DECREASED 69 0.0013
289 INJURY 90 0.0013
290 FLANK PAIN 12 0.0013
291 TREMOR 212 0.0013
292 SKIN TIGHTNESS 6 0.0013
293 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 258 0.0013
294 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 43 0.0013
295 DIVERTICULUM 9 0.0013
296 HYPOAESTHESIA ORAL 19 0.0013
297 RENAL CYST 10 0.0013
298 TRICUSPID VALVE INCOMPETENCE 10 0.0013
299 HYPERSOMNIA 36 0.0013
300 NON-SMALL CELL LUNG CANCER 6 0.0013
301 SINUSITIS 128 0.0012
302 INCORRECT PRODUCT ADMINISTRATION DURATION 27 0.0012
303 ROTATOR CUFF SYNDROME 16 0.0012
304 INSURANCE ISSUE 19 0.0012
305 PERIPHERAL COLDNESS 17 0.0012
306 HAEMORRHOIDS 24 0.0012
307 INCONTINENCE 13 0.0012
308 DIZZINESS 613 0.0012
309 ORAL DISCOMFORT 17 0.0012
310 KIDNEY INFECTION 24 0.0012
311 VISUAL DISTURBANCE 7 0.0012
312 SPINAL OPERATION 15 0.0012
313 BEDRIDDEN 16 0.0012
314 SPRUE-LIKE ENTEROPATHY 6 0.0012
315 IMPAIRED WORK ABILITY 26 0.0012
316 EXPOSURE DURING PREGNANCY 75 0.0012
317 HYDRONEPHROSIS 9 0.0012
318 LOSS OF CONSCIOUSNESS 154 0.0012
319 LIP SWELLING 40 0.0012
320 HEAD DISCOMFORT 21 0.0012
321 BLOOD IRON DECREASED 14 0.0012
322 NEPHROPATHY 11 0.0012
323 MIDDLE INSOMNIA 22 0.0012
324 MENORRHAGIA 23 0.0012
325 CENTRAL NERVOUS SYSTEM LESION 16 0.0012
326 ABNORMAL SENSATION IN EYE 5 0.0012
327 ABNORMAL DREAMS 32 0.0012
328 CRYING 42 0.0012
329 MALABSORPTION 6 0.0011
330 THROAT TIGHTNESS 31 0.0011
331 ARTHRITIS 90 0.0011
332 CONTUSION 110 0.0011
333 BLOOD CALCIUM INCREASED 10 0.0011
334 NASAL DISCOMFORT 9 0.0011
335 DUODENAL ULCER 8 0.0011
336 SOMNOLENCE 228 0.0011
337 VERTIGO 69 0.0011
338 EAR PAIN 22 0.0011
339 APHASIA 34 0.0011
340 VOMITING 529 0.0011
341 TOOTH DISORDER 25 0.0011
342 ACCIDENTAL OVERDOSE 41 0.0011
343 NIGHT SWEATS 36 0.0011
344 LIGAMENT SPRAIN 11 0.0011
345 MULTIPLE INJURIES 7 0.0011
346 MUSCLE DISORDER 9 0.0011
347 HEAD INJURY 35 0.0011
348 THYROID DISORDER 17 0.0011
349 IMPAIRED GASTRIC EMPTYING 15 0.0011
350 UTERINE LEIOMYOMA 8 0.0011
351 NONSPECIFIC REACTION 6 0.0011
352 EAR INFECTION 29 0.0011
353 MACULAR DEGENERATION 13 0.0011
354 MENSTRUAL DISORDER 9 0.0011
355 LIVER DISORDER 48 0.0011
356 CEREBRAL DISORDER 8 0.0011
357 HEART RATE ABNORMAL 6 0.0011
358 APHONIA 15 0.0011
359 CHEST PAIN 199 0.0011
360 BLOOD PRESSURE INCREASED 164 0.0011
361 THROAT IRRITATION 48 0.0011
362 SPEECH DISORDER 56 0.0011
363 SENSATION OF FOREIGN BODY 9 0.0011
364 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
365 DEPRESSION 242 0.0011
366 TOOTH INFECTION 14 0.0011
367 BLOOD URINE PRESENT 20 0.0011
368 MUSCULOSKELETAL PAIN 55 0.0010
369 BREAST MASS 7 0.0010
370 JOINT DISLOCATION 11 0.0010
371 RENAL FAILURE CHRONIC 8 0.0010
372 HOT FLUSH 78 0.0010
373 MUSCULOSKELETAL CHEST PAIN 16 0.0010
374 PRODUCT LABEL ISSUE 7 0.0010
375 MEMORY IMPAIRMENT 141 0.0010
376 AUTOIMMUNE DISORDER 10 0.0010
377 CHEST DISCOMFORT 105 0.0010
378 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
379 WITHDRAWAL SYNDROME 43 0.0010
380 PARAESTHESIA 161 0.0010
381 FLATULENCE 58 0.0010
382 EYE MOVEMENT DISORDER 7 0.0010
383 DYSPHAGIA 97 0.0010
384 CROHN'S DISEASE 7 0.0010
385 ILL-DEFINED DISORDER 62 0.0010
386 COAGULOPATHY 17 0.0010
387 BALANCE DISORDER 88 0.0010
388 ENERGY INCREASED 6 0.0010
389 URINARY INCONTINENCE 30 0.0010
390 ILLNESS 104 0.0010
391 MULTIPLE SCLEROSIS RELAPSE 69 0.0010
392 CYSTITIS 32 0.0010
393 FEAR 27 0.0010
394 COORDINATION ABNORMAL 14 0.0010
395 EXTRASYSTOLES 7 0.0010
396 FOOT FRACTURE 19 0.0010
397 BURNING SENSATION 70 0.0010
398 MUSCLE TWITCHING 23 0.0010
399 BLOOD POTASSIUM DECREASED 30 0.0010
400 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
401 PAPULE 7 0.0010
402 DYSSTASIA 29 0.0010
403 PRODUCT SUBSTITUTION ISSUE 57 0.0010
404 MUSCULOSKELETAL DISCOMFORT 17 0.0010
405 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
406 TOOTH ABSCESS 10 0.0010
407 TRANSIENT ISCHAEMIC ATTACK 33 0.0010
408 LOCAL SWELLING 17 0.0010
409 EYE HAEMORRHAGE 13 0.0010
410 HYPERAESTHESIA 8 0.0010
411 PRURITUS GENERALISED 21 0.0010
412 DEEP VEIN THROMBOSIS 63 0.0010
413 TONGUE DISORDER 7 0.0010
414 BLOOD CHOLESTEROL INCREASED 45 0.0010
415 SINUS CONGESTION 13 0.0010
416 BRONCHITIS 71 0.0010
417 INTENTIONAL PRODUCT USE ISSUE 84 0.0010
418 INTENTIONAL UNDERDOSE 7 0.0010
419 ATRIAL SEPTAL DEFECT 8 0.0010
420 ORAL DISORDER 7 0.0010
421 RECTAL HAEMORRHAGE 41 0.0010
422 SPINAL DISORDER 9 0.0009
423 BRAIN OEDEMA 12 0.0009
424 BLINDNESS TRANSIENT 7 0.0009
425 GOUT 17 0.0009
426 PULMONARY EMBOLISM 90 0.0009
427 BACK PAIN 220 0.0009
428 PRESYNCOPE 23 0.0009
429 PRODUCT ADMINISTRATION ERROR 19 0.0009
430 LIMB DISCOMFORT 29 0.0009
431 SENSORY DISTURBANCE 15 0.0009
432 CONSTIPATION 203 0.0009
433 HEART RATE IRREGULAR 21 0.0009
434 OROPHARYNGEAL PAIN 86 0.0009
435 DYSGEUSIA 69 0.0009
436 POOR QUALITY DRUG ADMINISTERED 6 0.0009
437 PSYCHOLOGICAL TRAUMA 8 0.0009
438 DISEASE RECURRENCE 44 0.0009
439 RIB FRACTURE 19 0.0009
440 AMNESIA 60 0.0009
441 ACCIDENT 11 0.0009
442 MULTIPLE SCLEROSIS 44 0.0009
443 POLYP 6 0.0009
444 ORAL CANDIDIASIS 12 0.0009
445 GROIN PAIN 8 0.0009
446 DYSGRAPHIA 6 0.0009
447 DISTURBANCE IN ATTENTION 49 0.0009
448 NOCTURIA 11 0.0009
449 HAEMATOCHEZIA 50 0.0009
450 APPETITE DISORDER 6 0.0009
451 TENDONITIS 14 0.0009
452 UPPER LIMB FRACTURE 18 0.0009
453 VISION BLURRED 124 0.0009
454 LIVER INJURY 22 0.0009
455 QUALITY OF LIFE DECREASED 12 0.0009
456 CARDIOMEGALY 11 0.0009
457 LACRIMATION INCREASED 27 0.0009
458 SKIN DISCOLOURATION 41 0.0009
459 MUSCLE SPASMS 163 0.0009
460 PRODUCT TASTE ABNORMAL 12 0.0009
461 MALAISE 387 0.0009
462 SLUGGISHNESS 9 0.0009
463 HERNIA 17 0.0009
464 PAIN 540 0.0009
465 BONE DISORDER 16 0.0009
466 EAR DISCOMFORT 9 0.0009
467 HYPOTHYROIDISM 28 0.0009
468 INFLUENZA LIKE ILLNESS 72 0.0009
469 MENTAL DISORDER 38 0.0009
470 TEMPERATURE INTOLERANCE 9 0.0009
471 ABDOMINAL DISTENSION 91 0.0009
472 ABDOMINAL PAIN LOWER 22 0.0009
473 MUSCLE ATROPHY 11 0.0009
474 NERVE COMPRESSION 8 0.0009
475 GRAND MAL CONVULSION 8 0.0009
476 IRRITABILITY 52 0.0009
477 INJECTION SITE IRRITATION 11 0.0009
478 LARGE INTESTINE PERFORATION 6 0.0009
479 HYPERTENSION 183 0.0009
480 POLLAKIURIA 36 0.0009
481 PRODUCT ODOUR ABNORMAL 9 0.0009
482 TRANSFUSION 9 0.0009
483 MASS 12 0.0009
484 ECONOMIC PROBLEM 13 0.0009
485 THROMBOSIS 69 0.0009
486 ANGER 29 0.0009
487 CARPAL TUNNEL SYNDROME 12 0.0009
488 OSTEOPENIA 13 0.0009
489 APPENDICITIS 8 0.0009
490 VAGINAL HAEMORRHAGE 37 0.0009
491 NASAL CONGESTION 50 0.0008
492 ABASIA 21 0.0008
493 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
494 GASTROINTESTINAL DISORDER 76 0.0008
495 HAND FRACTURE 6 0.0008
496 SPINAL COMPRESSION FRACTURE 7 0.0008
497 HYPERHIDROSIS 109 0.0008
498 UPPER RESPIRATORY TRACT INFECTION 39 0.0008
499 BODY HEIGHT DECREASED 9 0.0008
500 DEAFNESS 22 0.0008
501 CONVULSION 48 0.0008
502 NIGHTMARE 29 0.0008
503 BONE PAIN 49 0.0008
504 URTICARIA 140 0.0008
505 FATIGUE 649 0.0008
506 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
507 VISUAL FIELD DEFECT 6 0.0008
508 BRAIN FOG 13 0.0008
509 CHILLS 97 0.0008
510 PRESCRIBED OVERDOSE 16 0.0008
511 WRONG TECHNIQUE IN DRUG USAGE PROCESS 30 0.0008
512 OSTEOARTHRITIS 35 0.0008
513 DIZZINESS POSTURAL 8 0.0008
514 HAEMOPTYSIS 23 0.0008
515 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14 0.0008
516 DRUG EXPOSURE DURING PREGNANCY 28 0.0008
517 NEURALGIA 20 0.0008
518 SLEEP DISORDER 58 0.0008
519 DYSPHONIA 48 0.0008
520 PAIN IN EXTREMITY 241 0.0008
521 MOOD SWINGS 26 0.0008
522 FALL 271 0.0008
523 THERAPY CHANGE 8 0.0008
524 HYPERSENSITIVITY 151 0.0008
525 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
526 SKIN HAEMORRHAGE 12 0.0008
527 THERAPEUTIC RESPONSE DECREASED 49 0.0008
528 HAEMATOCRIT DECREASED 16 0.0008
529 HEPATIC STEATOSIS 15 0.0008
530 THINKING ABNORMAL 15 0.0008
531 GAIT DISTURBANCE 154 0.0008
532 GLOSSODYNIA 18 0.0008
533 SWOLLEN TONGUE 25 0.0008
534 RENAL FAILURE 106 0.0008
535 SUICIDAL IDEATION 73 0.0008
536 ABDOMINAL PAIN 185 0.0008
537 PRODUCT COMMUNICATION ISSUE 7 0.0008
538 UNEVALUABLE EVENT 60 0.0008
539 LUNG INFILTRATION 7 0.0008
540 RESTLESSNESS 29 0.0008
541 FEELING COLD 22 0.0008
542 INJECTION SITE BRUISING 63 0.0008
543 DRY MOUTH 64 0.0008
544 MUSCULOSKELETAL STIFFNESS 69 0.0008
545 WRONG DRUG ADMINISTERED 7 0.0008
546 MOTOR DYSFUNCTION 8 0.0008
547 THERAPEUTIC RESPONSE SHORTENED 26 0.0008
548 PROCEDURAL COMPLICATION 6 0.0008
549 LOWER LIMB FRACTURE 15 0.0008
550 BLINDNESS UNILATERAL 11 0.0008
551 RENAL INJURY 23 0.0008
552 CAESAREAN SECTION 9 0.0008
553 RASH MACULAR 27 0.0008
554 VENTRICULAR EXTRASYSTOLES 8 0.0008
555 PHARMACEUTICAL PRODUCT COMPLAINT 20 0.0008
556 MOOD ALTERED 21 0.0008
557 EYE DISCHARGE 8 0.0008
558 HEMIPARESIS 13 0.0008
559 PLATELET COUNT INCREASED 10 0.0008
560 WEIGHT FLUCTUATION 8 0.0008
561 PREMATURE BABY 23 0.0008
562 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
563 AFFECTIVE DISORDER 6 0.0008
564 JOINT STIFFNESS 20 0.0008
565 METRORRHAGIA 13 0.0008
566 EYE PAIN 43 0.0008
567 ORAL PAIN 17 0.0008
568 HYPOKINESIA 11 0.0008
569 APATHY 11 0.0008
570 PARANOIA 13 0.0008
571 GINGIVAL PAIN 6 0.0008
572 PERSONALITY CHANGE 7 0.0008
573 HYPERLIPIDAEMIA 9 0.0008
574 DIARRHOEA HAEMORRHAGIC 7 0.0007
575 EPISTAXIS 56 0.0007
576 SPINAL FRACTURE 15 0.0007
577 GAIT INABILITY 25 0.0007
578 FLUSHING 76 0.0007
579 MALIGNANT MELANOMA 10 0.0007
580 EMOTIONAL DISORDER 23 0.0007
581 RHINITIS 6 0.0007
582 EYE PRURITUS 25 0.0007
583 CONDITION AGGRAVATED 226 0.0007
584 FRUSTRATION TOLERANCE DECREASED 6 0.0007
585 BURSITIS 9 0.0007
586 ADRENAL INSUFFICIENCY 9 0.0007
587 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
588 DECREASED ACTIVITY 8 0.0007
589 COLITIS 28 0.0007
590 NO THERAPEUTIC RESPONSE 9 0.0007
591 COLD SWEAT 13 0.0007
592 DISORIENTATION 29 0.0007
593 RENAL DISORDER 34 0.0007
594 SYNCOPE 73 0.0007
595 ESCHERICHIA INFECTION 6 0.0007
596 SKIN LESION 20 0.0007
597 POST PROCEDURAL COMPLICATION 14 0.0007
598 AFFECT LABILITY 7 0.0007
599 ADVERSE DRUG REACTION 65 0.0007
600 TOOTH LOSS 15 0.0007
601 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
602 PROCEDURAL PAIN 20 0.0007
603 DEPRESSED MOOD 38 0.0007
604 DYSARTHRIA 27 0.0007
605 PELVIC PAIN 13 0.0007
606 PHARYNGEAL SWELLING 7 0.0007
607 RENAL TUBULAR NECROSIS 7 0.0007
608 OCULAR DISCOMFORT 8 0.0007
609 VITREOUS FLOATERS 7 0.0007
610 KNEE OPERATION 7 0.0007
611 URINARY TRACT INFECTION 121 0.0007
612 UTERINE PERFORATION 6 0.0007
613 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 34 0.0007
614 BLOOD PRESSURE ABNORMAL 14 0.0007
615 FEELING HOT 43 0.0007
616 RED BLOOD CELL COUNT DECREASED 20 0.0007
617 LIVER FUNCTION TEST INCREASED 15 0.0007
618 PARALYSIS 10 0.0007
619 ANOREXIA 9 0.0007
620 BRAIN INJURY 7 0.0007
621 CARDIAC OPERATION 6 0.0007
622 RHINORRHOEA 45 0.0007
623 LETHARGY 40 0.0007
624 CARDIAC MURMUR 6 0.0007
625 RESPIRATORY TRACT CONGESTION 11 0.0007
626 SKIN SWELLING 6 0.0007
627 FUNGAL INFECTION 23 0.0007
628 EYELID PTOSIS 7 0.0007
629 DRY THROAT 7 0.0007
630 SUBARACHNOID HAEMORRHAGE 7 0.0007
631 POST PROCEDURAL HAEMORRHAGE 8 0.0007
632 BODY TEMPERATURE INCREASED 14 0.0007
633 NAIL DISORDER 6 0.0007
634 DIVERTICULITIS 19 0.0007
635 COGNITIVE DISORDER 32 0.0007
636 MOVEMENT DISORDER 22 0.0007
637 SPLENOMEGALY 8 0.0007
638 SURGERY 40 0.0007
639 DIABETES MELLITUS 52 0.0007
640 GASTROINTESTINAL HAEMORRHAGE 57 0.0007
641 GRIP STRENGTH DECREASED 6 0.0007
642 ASTHMA 77 0.0007
643 INCREASED APPETITE 13 0.0007
644 DYSURIA 25 0.0007
645 LYMPHOCYTE COUNT DECREASED 12 0.0007
646 ADVERSE REACTION 9 0.0007
647 LABORATORY TEST ABNORMAL 20 0.0007
648 MUSCULAR WEAKNESS 77 0.0007
649 GLAUCOMA 13 0.0007
650 DEHYDRATION 90 0.0007
651 ASTHENIA 253 0.0007
652 DISCOMFORT 41 0.0007
653 CEREBRAL HAEMORRHAGE 24 0.0007
654 GASTROINTESTINAL INFECTION 6 0.0007
655 VISUAL ACUITY REDUCED 22 0.0007
656 ADVERSE EVENT 61 0.0007
657 VISUAL IMPAIRMENT 82 0.0007
658 SKIN DISORDER 22 0.0007
659 BLOOD COUNT ABNORMAL 10 0.0007
660 WEIGHT DECREASED 184 0.0007
661 GINGIVAL BLEEDING 9 0.0007
662 PRODUCT DOSE OMISSION 43 0.0007
663 UNRESPONSIVE TO STIMULI 17 0.0007
664 EATING DISORDER 14 0.0007
665 BREAST PAIN 7 0.0007
666 OEDEMA PERIPHERAL 80 0.0007
667 PERIPHERAL SWELLING 101 0.0007
668 HEART RATE DECREASED 23 0.0007
669 CELLULITIS 33 0.0007
670 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 118 0.0007
671 RESPIRATORY TRACT INFECTION 17 0.0007
672 DIARRHOEA 421 0.0007
673 ARTHRALGIA 271 0.0007
674 DYSPNOEA 368 0.0006
675 SMALL INTESTINAL OBSTRUCTION 8 0.0006
676 LYMPHADENOPATHY 23 0.0006
677 ANKLE FRACTURE 10 0.0006
678 NASOPHARYNGITIS 119 0.0006
679 SKIN LACERATION 7 0.0006
680 HEPATIC ENCEPHALOPATHY 6 0.0006
681 TOOTH EXTRACTION 8 0.0006
682 FEEDING DISORDER 13 0.0006
683 BASAL CELL CARCINOMA 10 0.0006
684 OESOPHAGITIS 7 0.0006
685 PSORIATIC ARTHROPATHY 26 0.0006
686 INFLAMMATION 33 0.0006
687 COUGH 179 0.0006
688 ARTERIOSCLEROSIS 6 0.0006
689 INFLUENZA 71 0.0006
690 BLOOD SODIUM DECREASED 12 0.0006
691 SINUS TACHYCARDIA 9 0.0006
692 NEUROPATHY PERIPHERAL 60 0.0006
693 PRURITUS 242 0.0006
694 RASH PRURITIC 34 0.0006
695 ABSCESS 10 0.0006
696 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
697 MALNUTRITION 7 0.0006
698 BLOOD PRESSURE FLUCTUATION 15 0.0006
699 BLOOD CALCIUM DECREASED 7 0.0006
700 CEREBROVASCULAR ACCIDENT 105 0.0006
701 SWELLING 58 0.0006
702 BLOOD PRESSURE DECREASED 41 0.0006
703 WEIGHT INCREASED 138 0.0006
704 DIPLOPIA 16 0.0006
705 HALLUCINATION, VISUAL 13 0.0006
706 THIRST 11 0.0006
707 MYOCARDIAL ISCHAEMIA 7 0.0006
708 FEMUR FRACTURE 19 0.0006
709 INTERNAL HAEMORRHAGE 7 0.0006
710 HALLUCINATION 46 0.0006
711 STOMATITIS 37 0.0006
712 DISABILITY 12 0.0006
713 STAPHYLOCOCCAL INFECTION 20 0.0006
714 CATARACT 36 0.0006
715 EYELID OEDEMA 7 0.0006
716 ABORTION SPONTANEOUS 24 0.0006
717 MOBILITY DECREASED 43 0.0006
718 BLOOD UREA INCREASED 10 0.0006
719 MATERNAL EXPOSURE DURING PREGNANCY 53 0.0006
720 MYALGIA 101 0.0006
721 VAGINAL DISCHARGE 6 0.0006
722 MELAENA 13 0.0006
723 ATAXIA 7 0.0006
724 BLINDNESS 24 0.0006
725 PALLOR 16 0.0006
726 DECREASED APPETITE 136 0.0006
727 ACUTE HEPATIC FAILURE 8 0.0006
728 HAEMORRHAGE 61 0.0006
729 CORONARY ARTERY OCCLUSION 8 0.0006
730 PRODUCT STORAGE ERROR 51 0.0006
731 INJECTION SITE PRURITUS 39 0.0006
732 HEPATITIS C 7 0.0006
733 HAEMATOMA 15 0.0006
734 THERAPY NON-RESPONDER 26 0.0006
735 INTENTIONAL OVERDOSE 37 0.0006
736 PSYCHOTIC DISORDER 17 0.0006
737 HERPES ZOSTER 33 0.0006
738 ACUTE RESPIRATORY FAILURE 11 0.0006
739 SEIZURE 66 0.0006
740 ANHEDONIA 15 0.0006
741 OCULAR HYPERAEMIA 27 0.0006
742 ERUCTATION 11 0.0006
743 DYSTONIA 11 0.0006
744 OBESITY 9 0.0006
745 TYPE 2 DIABETES MELLITUS 19 0.0006
746 ERYTHEMA 116 0.0006
747 SKIN FISSURES 11 0.0006
748 EMOTIONAL DISTRESS 68 0.0006
749 MENSTRUATION IRREGULAR 15 0.0006
750 OSTEOPOROSIS 23 0.0006
751 DYSPNOEA EXERTIONAL 21 0.0006
752 INJECTION SITE ERYTHEMA 69 0.0006
753 ATRIAL FIBRILLATION 54 0.0006
754 MENSTRUATION DELAYED 6 0.0006
755 OSTEOMYELITIS 10 0.0006
756 PULMONARY THROMBOSIS 6 0.0005
757 LIVER FUNCTION TEST ABNORMAL 16 0.0005
758 METASTASES TO BONE 9 0.0005
759 HYPOPHAGIA 14 0.0005
760 MYDRIASIS 7 0.0005
761 INJECTION SITE NODULE 6 0.0005
762 ALOPECIA 107 0.0005
763 SKIN BURNING SENSATION 39 0.0005
764 TASTE DISORDER 11 0.0005
765 VIRAL INFECTION 18 0.0005
766 MENTAL STATUS CHANGES 15 0.0005
767 INJECTION SITE INDURATION 7 0.0005
768 NODULE 7 0.0005
769 MENTAL IMPAIRMENT 13 0.0005
770 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
771 ACUTE KIDNEY INJURY 82 0.0005
772 HAEMOGLOBIN DECREASED 55 0.0005
773 OEDEMA 29 0.0005
774 BLISTER 30 0.0005
775 APPLICATION SITE ERYTHEMA 14 0.0005
776 CANDIDA INFECTION 9 0.0005
777 ABORTION INDUCED 5 0.0005
778 HEPATIC FAILURE 16 0.0005
779 THERAPY CESSATION 27 0.0005
780 HAEMATURIA 18 0.0005
781 MUSCULOSKELETAL DISORDER 10 0.0005
782 CARDIAC DISORDER 49 0.0005
783 ANGINA PECTORIS 15 0.0005
784 HIP ARTHROPLASTY 8 0.0005
785 NEOPLASM 6 0.0005
786 PULMONARY FIBROSIS 10 0.0005
787 FREQUENT BOWEL MOVEMENTS 14 0.0005
788 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
789 AGITATION 38 0.0005
790 VASCULITIS 6 0.0005
791 EJECTION FRACTION DECREASED 8 0.0005
792 AMENORRHOEA 9 0.0005
793 THERAPY PARTIAL RESPONDER 8 0.0005
794 FLUID RETENTION 26 0.0005
795 URINARY RETENTION 17 0.0005
796 WHEEZING 30 0.0005
797 INJECTION SITE PAIN 155 0.0005
798 PNEUMOTHORAX 8 0.0005
799 FOETAL EXPOSURE DURING PREGNANCY 41 0.0005
800 HALLUCINATION, AUDITORY 8 0.0005
801 HYPOMAGNESAEMIA 7 0.0005
802 CONFUSIONAL STATE 81 0.0005
803 WOUND 14 0.0005
804 HIP FRACTURE 16 0.0005
805 FULL BLOOD COUNT DECREASED 10 0.0005
806 TACHYCARDIA 44 0.0005
807 PLEURAL EFFUSION 30 0.0005
808 INJECTION SITE URTICARIA 12 0.0005
809 IMPAIRED HEALING 16 0.0005
810 MANIA 8 0.0005
811 HYPERCALCAEMIA 6 0.0005
812 COVID-19 85 0.0005
813 PHOTOSENSITIVITY REACTION 8 0.0005
814 ANOSMIA 7 0.0005
815 BACTERIAL INFECTION 9 0.0005
816 HAIR COLOUR CHANGES 6 0.0005
817 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
818 PRODUCTIVE COUGH 23 0.0005
819 AGEUSIA 12 0.0005
820 DRY EYE 24 0.0005
821 NERVOUS SYSTEM DISORDER 15 0.0005
822 PULMONARY HYPERTENSION 10 0.0005
823 GASTROENTERITIS 7 0.0005
824 SUICIDE ATTEMPT 29 0.0005
825 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
826 COLON CANCER 7 0.0005
827 HEPATITIS 12 0.0005
828 DRUG PRESCRIBING ERROR 9 0.0005
829 RESPIRATORY DISORDER 14 0.0005
830 DRUG DOSE OMISSION 77 0.0005
831 SKIN CANCER 10 0.0005
832 CORONARY ARTERY DISEASE 14 0.0005
833 ORAL HERPES 9 0.0005
834 DEVICE FAILURE 7 0.0005
835 EYE DISORDER 15 0.0005
836 RASH 198 0.0005
837 WHITE BLOOD CELL COUNT DECREASED 49 0.0005
838 PSORIASIS 59 0.0005
839 INTESTINAL OBSTRUCTION 17 0.0005
840 ANAEMIA 86 0.0005
841 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
842 DELUSION 7 0.0005
843 ARTHROPATHY 25 0.0004
844 HAIR TEXTURE ABNORMAL 6 0.0004
845 RENAL FAILURE ACUTE 19 0.0004
846 PRODUCT DOSE OMISSION ISSUE 131 0.0004
847 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
848 UVEITIS 6 0.0004
849 RHEUMATOID ARTHRITIS 50 0.0004
850 JOINT SWELLING 53 0.0004
851 OFF LABEL USE 382 0.0004
852 PERICARDIAL EFFUSION 10 0.0004
853 DERMATITIS 9 0.0004
854 ERECTILE DYSFUNCTION 11 0.0004
855 BLOOD TEST ABNORMAL 6 0.0004
856 SKIN EXFOLIATION 36 0.0004
857 DEVICE OCCLUSION 6 0.0004
858 CARDIAC FAILURE CONGESTIVE 34 0.0004
859 NEOPLASM MALIGNANT 28 0.0004
860 DYSKINESIA 17 0.0004
861 HYPOACUSIS 18 0.0004
862 DRUG INTOLERANCE 40 0.0004
863 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
864 CEREBRAL INFARCTION 10 0.0004
865 JAUNDICE 11 0.0004
866 RASH PAPULAR 9 0.0004
867 DRUG WITHDRAWAL SYNDROME 35 0.0004
868 BLOOD GLUCOSE DECREASED 19 0.0004
869 PRODUCT AVAILABILITY ISSUE 9 0.0004
870 DEVICE DIFFICULT TO USE 26 0.0004
871 INFUSION RELATED REACTION 26 0.0004
872 ISCHAEMIC STROKE 7 0.0004
873 INJECTION SITE RASH 12 0.0004
874 DEVICE DISLOCATION 17 0.0004
875 MYOCARDIAL INFARCTION 68 0.0004
876 PNEUMONIA 126 0.0004
877 INJECTION SITE WARMTH 8 0.0004
878 ANAPHYLACTIC SHOCK 10 0.0004
879 PYREXIA 134 0.0004
880 COMPLICATION OF DEVICE REMOVAL 7 0.0004
881 INFECTION 56 0.0004
882 RASH GENERALISED 10 0.0004
883 ACNE 29 0.0004
884 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7 0.0004
885 SEDATION 10 0.0004
886 KNEE ARTHROPLASTY 8 0.0004
887 INJECTION SITE MASS 14 0.0004
888 INJECTION SITE HAEMORRHAGE 30 0.0004
889 LOCALISED INFECTION 9 0.0004
890 PAIN OF SKIN 10 0.0004
891 RESPIRATORY FAILURE 27 0.0004
892 DEVICE MALFUNCTION 26 0.0004
893 HYPOKALAEMIA 17 0.0004
894 HEPATIC ENZYME INCREASED 25 0.0004
895 TREATMENT NONCOMPLIANCE 20 0.0004
896 INJECTION SITE SWELLING 28 0.0004
897 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
898 EYE IRRITATION 21 0.0004
899 PRODUCT ADHESION ISSUE 13 0.0004
900 INJECTION SITE REACTION 25 0.0004
901 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
902 EPILEPSY 11 0.0004
903 HEPATOTOXICITY 8 0.0004
904 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
905 PANCREATITIS ACUTE 8 0.0004
906 FACE OEDEMA 6 0.0004
907 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
908 DRY SKIN 47 0.0004
909 SKIN ULCER 9 0.0003
910 ANAPHYLACTIC REACTION 19 0.0003
911 PULMONARY OEDEMA 15 0.0003
912 HYPOTENSION 67 0.0003
913 MOUTH ULCERATION 7 0.0003
914 ABNORMAL BEHAVIOUR 13 0.0003
915 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
916 DEMENTIA 9 0.0003
917 PANCREATITIS 17 0.0003
918 DRUG INTERACTION 51 0.0003
919 ACCIDENTAL EXPOSURE TO PRODUCT 33 0.0003
920 PNEUMONIA ASPIRATION 8 0.0003
921 TARDIVE DYSKINESIA 9 0.0003
922 BLOOD GLUCOSE INCREASED 60 0.0003
923 APPLICATION SITE PAIN 7 0.0003
924 SEPSIS 35 0.0003
925 RASH ERYTHEMATOUS 15 0.0003
926 SNEEZING 7 0.0003
927 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
928 NEEDLE ISSUE 9 0.0003
929 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
930 THERAPY INTERRUPTED 22 0.0003
931 C-REACTIVE PROTEIN INCREASED 11 0.0003
932 PRESCRIBED UNDERDOSE 6 0.0003
933 HOSPITALISATION 46 0.0003
934 COMA 14 0.0003
935 PRODUCT PREPARATION ERROR 6 0.0003
936 DEPENDENCE 16 0.0003
937 HYPOXIA 10 0.0003
938 OSTEONECROSIS OF JAW 7 0.0003
939 PLATELET COUNT DECREASED 30 0.0003
940 INTENTIONAL DOSE OMISSION 8 0.0003
941 AGGRESSION 14 0.0003
942 PRODUCT PRESCRIBING ISSUE 6 0.0003
943 ARRHYTHMIA 13 0.0003
944 HYPERGLYCAEMIA 10 0.0003
945 COLITIS ULCERATIVE 12 0.0003
946 BREAST CANCER 25 0.0003
947 ECZEMA 14 0.0003
948 INCORRECT DOSE ADMINISTERED BY DEVICE 7 0.0003
949 LUNG DISORDER 13 0.0003
950 APPLICATION SITE PRURITUS 6 0.0003
951 RHABDOMYOLYSIS 11 0.0003
952 DELIRIUM 9 0.0003
953 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
954 DRUG DOSE OMISSION BY DEVICE 20 0.0003
955 RESPIRATORY ARREST 7 0.0003
956 ENCEPHALOPATHY 6 0.0002
957 CARDIO-RESPIRATORY ARREST 10 0.0002
958 ACUTE MYOCARDIAL INFARCTION 7 0.0002
959 DISEASE PROGRESSION 28 0.0002
960 EXPOSURE VIA SKIN CONTACT 6 0.0002
961 DEVICE LEAKAGE 10 0.0002
962 BLOOD CREATININE INCREASED 15 0.0002
963 DERMATITIS ATOPIC 12 0.0002
964 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
965 BLOOD BILIRUBIN INCREASED 6 0.0002
966 CARDIAC ARREST 18 0.0002
967 RESPIRATORY DISTRESS 6 0.0002
968 TREATMENT FAILURE 18 0.0002
969 OXYGEN SATURATION DECREASED 12 0.0002
970 ASCITES 6 0.0002
971 RENAL IMPAIRMENT 17 0.0002
972 CARDIAC FAILURE 16 0.0002
973 SKIN IRRITATION 9 0.0002
974 NEUTROPHIL COUNT DECREASED 8 0.0002
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9 0.0002
976 BONE DENSITY DECREASED 6 0.0002
977 BRADYCARDIA 10 0.0002
978 METABOLIC ACIDOSIS 6 0.0002
979 ANGIOEDEMA 8 0.0002
980 DEVICE ISSUE 16 0.0002
981 NEOPLASM PROGRESSION 6 0.0002
982 DEVICE BREAKAGE 7 0.0002
983 NO ADVERSE EVENT 31 0.0002
984 DRUG ABUSE 14 0.0002
985 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
986 HYPOGLYCAEMIA 7 0.0001
987 THROMBOCYTOPENIA 15 0.0001
988 DEATH 94 0.0001
989 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
990 NEUTROPENIA 13 0.0001
991 TOXICITY TO VARIOUS AGENTS 12 0.0001